N-(bromoacetyl)-3,3-dinitroazetidine

N-(bromoacetyl)-3,3-dinitroazetidine
Trade Name
Orphan Indication Small cell lung cancer
USA Market Approval USA
USA Designation Date 2017-06-15 00:00:00
Sponsor EpicentRx, Inc.;4445 Eastgate Mall, Suite 200;San Diego, California, 92121